U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
90.07
+1.52 (1.72%)
Jan 21, 2025, 4:00 PM EST - Market closed
U.S. Physical Therapy Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for USPH stock have an average target of 114, with a low estimate of 108 and a high estimate of 120. The average target predicts an increase of 26.57% from the current stock price of 90.07.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 16, 2024.
Analyst Ratings
The average analyst rating for USPH stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 3 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $100 → $115 | Hold → Strong Buy | Upgrades | $100 → $115 | +27.68% | Dec 16, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $113 | Buy | Initiates | $113 | +25.46% | Dec 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +33.23% | Dec 3, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $108 | Buy | Maintains | $108 | +19.91% | Nov 21, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $108 | Buy | Maintains | $108 | +19.91% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
679.00M
from 598.63M
Increased by 13.43%
Revenue Next Year
759.24M
from 679.00M
Increased by 11.82%
EPS This Year
2.70
from 1.28
Increased by 110.96%
EPS Next Year
2.94
from 2.70
Increased by 8.97%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 705.5M | 815.9M | 876.7M |
| Avg | 679.0M | 759.2M | 809.5M |
| Low | 647.1M | 716.2M | 760.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 17.9% | 20.2% | 15.5% |
| Avg | 13.4% | 11.8% | 6.6% |
| Low | 8.1% | 5.5% | 0.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.01 | 3.38 | 3.78 |
| Avg | 2.70 | 2.94 | 3.29 |
| Low | 2.44 | 2.47 | 2.82 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 135.7% | 25.4% | 28.6% |
| Avg | 111.0% | 9.0% | 11.8% |
| Low | 90.9% | -8.4% | -4.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.